Trading Members of the Exchange are hereby informed that effective from November 18, 2025, the Equity Shares of Mahamaya Lifesciences Ltd (Scrip Code: 544611) are listed and admitted to ....

Capital Market EventsExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

—

prior close

₹116.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.0%—

Pesticides & Agrochemicals peers, median of 27sector-1.5%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+5.0

15m

+0.0

30m

+0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-0.8—-1.2—

Next day

—-1.0—-1.5—

—-1.3—-1.2—

—-2.8—-1.2—

—-3.4—-3.2—

—-3.3—-1.6—

—-2.4—-0.7—

15d

—-5.8—-3.8—

—-7.0—-6.5—

—-9.8—-9.3—

—-7.1—-9.2—

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mahamaya Lifesciences Ltd has been listed and admitted to trading on BSE effective November 18, 2025, under scrip code 544611. The announcement informs trading members about the commencement of trading in the company's equity shares. This marks the company's entry into the public market via the BSE platform.

Likely market impact

The stock will be available for trading from November 18, 2025, giving investors an opportunity to buy shares of Mahamaya Lifesciences. Early trading periods for newly listed stocks often see price volatility as the market discovers a fair price.